Amgen Inc (NASDAQ:AMGN)

218.22
Delayed Data
As of Nov 13
 -1.64 / -0.74%
Today’s Change
166.30
Today|||52-Week Range
225.26
+12.10%
Year-to-Date
AMGN Regular Dividend: AMGN will begin trading ex-dividend today with a $1.45 dividend payable to shareholders of record as of 11/15/19.
Amarin's Stock Could Reach $50 Per Share Soon
Nov 13 / MotleyFool.com - Paid Partner Content
Here's Why Cytokinetics Stock Tanked on Thursday
Nov 07 / MotleyFool.com - Paid Partner Content
Here’s Why FibroGen’s Stock Popped Friday
Nov 11 / MotleyFool.com - Paid Partner Content
Buy These 2 Stocks to Access China's Huge Healthcare Market
Nov 06 / MotleyFool.com - Paid Partner Content
Why Amgen's Stock Soared in October
Nov 11 / MotleyFool.com - Paid Partner Content
Better Buy: Mirati Therapeutics vs. Amgen
Nov 02 / MotleyFool.com - Paid Partner Content
3 Cancer Treatment Stocks to Buy Right Now
Nov 09 / MotleyFool.com - Paid Partner Content
Here's Why Beigene Stock Is Soaring Today
Nov 01 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close221.31
Today’s open220.43
Day’s range218.54 - 221.69
Volume2,349,050
Average volume (3 months)2,823,896
Market cap$131.0B
Data as of 4:15pm ET, 11/13/2019

Growth & Valuation

Earnings growth (last year)+368.59%
Earnings growth (this year)+0.16%
Earnings growth (next 5 years)+8.00%
Revenue growth (last year)+4.32%
P/E ratio16.9
Price/Sales5.45
Price/Book11.10

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-0.99-1.54%
BIIBBiogen-9.51-3.26%
ILMNIllumina Inc+2.49+0.84%
BMRNBiomarin Pharmaceuti...+0.26+0.34%
Data as of 4:15pm ET, 11/13/2019

Financials

Next reporting dateJanuary 30, 2020
EPS forecast (this quarter)$3.25
Annual revenue (last year)$23.8B
Annual profit (last year)$8.4B
Net profit margin35.32%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Thousand Oaks, California

Forecasts